According to previous publications from our group and other research teams, STIM1 and ORAI1 are implicated in metastasis of prostate cancer, as it has been shown to promote invasion, migration, and EMT in prostate cancer cells (Xu et al., 2015; Stagno et al., 2017; Zhou et al., 2017). Here, ORAI1 is linked to prostate carcinoma.